Fluorinated arylamide derivatives

Details for Australian Patent Application No. 2007208494 (hide)

Owner Merck & Co., Inc.

Inventors Miller, Thomas A.; Wilson, Kevin J.; Stanton, Matthew G.; Witter, David J.; Sloman, David L.

Agent Spruson & Ferguson

Pub. Number AU-A-2007208494

PCT Pub. Number WO2007/087129

Priority 60/758,357 12.01.06 US

Filing date 9 January 2007

Wipo publication date 2 August 2007

International Classifications

A61K 31/5377 (2006.01)

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/087129 Priority application(s): WO2007/087129

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

29 April 2010 Application with amended filing dates

  Merck Sharp & Dohme Corp. The filing date has been amended to 08.01.2007

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007208495-Hydroxyalkylarylamide derivatives

2007208482-Complex-transform channel coding with extended-band frequency coding